Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication.

Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2002 Mar; 16(3):527-32.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.